Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial.
      Google Scholar   
Citation:
JAMA
Year:
2024
Type:
Manuscript
Funding:
AFT PCORI
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
4493  
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
PCS-1505-30497 / CER-1503-29572, BCRF-23-074, SPEC-24-020, SPEC-22-021  
Corr. Author:
 
Authors:
                                                                           
Networks:
AURORA, CA016, CAPITAL, CRCWM, KAISER, KANSAS, LAPS-CT018, LAPS-MA036, LAPS-MO011, LAPS-NC007, LAPS-NC010, LAPS-PA015, LAPS-TX035, METROMIN, NY018, NY167, PA125, TX041   
Study
AFT-25
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
N/A
Keywords: